CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives.
This study was performed to assess the influence of age, sex, smoking, and contraceptive use on CYP2A6 activity. In the metabolism of caffeine, the conversion of 1,7 dimethylxanthine (17X) to 1,7 dimethiylurate (17U) is catalyzed primarily by CYP2A6. CYP2A6 phenotype was determined by the urinary ratio 17U:17X in the interval of 4-5 h after caffeine intake in 179 healthy white Spaniards (102 women and 76 men). There were 99 non-smokers and 80 smokers. Among women, 26 were taking oral contraceptives. The age was the most important predictive factor of CYP2A6 activity (P < 0.001) with older subjects having higher activity. The influence of the gender was more modest (P = 0.07) with women exhibiting borderline increased values of the CYP2A6 marker than men. Tobacco smoking did not affect CYP2A6 activity. However, the CYP2A6 marker resulted to be strongly related to the use of oral contraceptives. The women users of oral contraceptives had higher values of CYP2A6 marker than both women not taking oral contraceptives and men (P < 0.001 in both comparisons). The results indicate that age, oral contraceptive use, and possibly gender should be controlled in epidemiological studies dealing with CYP2A6 activity and its relationship with xenobiotics exposure and genetic or pathological factor.
Sinues
B
B
Department of Pharmacology, Medicine School, University of Zaragoza, Zaragoza, Spain. bsinues@unizar.es
Fanlo
A
A
Mayayo
E
E
Carcas
C
C
Vicente
J
J
Arenaz
I
I
Cebollada
A
A
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001189:Aryl Hydrocarbon Hydroxylases / Q000378:metabolism*; D015415:Biomarkers / Q000652:urine; D002110:Caffeine / Q000008:administration & dosage; D003276:Contraceptives, Oral; D065637:Cytochrome P-450 CYP2A6; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D012307:Risk Factors; D012737:Sex Factors; D012907:Smoking; D013030:Spain; D013806:Theophylline / Q000652:urine; D014527:Uric Acid / Q000031:analogs & derivatives / Q000652:urine
D015415:Biomarkers; D003276:Contraceptives, Oral; D014527:Uric Acid; D002110:Caffeine; D013806:Theophylline; D001189:Aryl Hydrocarbon Hydroxylases; C585710:CYP2A6 protein, human; D065637:Cytochrome P-450 CYP2A6; C021183:1,7-dimethylxanthine; C053084:1,7-dimethyluric acid